14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Nov 02, 2023 Buy 23 398 Kayne Richard A Common Stock
Nov 01, 2023 Buy 100 000 Kayne Richard A Common Stock
Oct 31, 2023 Buy 130 509 Kayne Richard A Common Stock
Oct 31, 2023 Buy 12 345 Kayne Richard A Common Stock
Oct 31, 2023 Buy 11 987 Kayne Richard A Common Stock
Oct 31, 2023 Buy 12 345 Kawas Leen Common Stock
Oct 31, 2023 Buy 11 987 Kawas Leen Common Stock
Oct 18, 2023 Buy 0 Kayne Richard A Common Stock
Oct 18, 2023 Buy 0 Kayne Richard A Common Stock
Oct 18, 2023 Buy 0 Kayne Richard A Common Stock
Oct 18, 2023 Buy 0 Kawas Leen Common Stock
Oct 18, 2023 Buy 0 Kawas Leen Common Stock
Aug 31, 2023 Buy 54 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 0 Choong Ingrid Common Stock
Aug 30, 2023 Buy 0 Choong Ingrid Common Stock
Aug 30, 2023 Buy 7 490 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 25 750 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 13 200 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 25 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 17 500 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 10 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 35 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 60 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 17 500 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 98 000 Choong Ingrid Stock Option (Right to Buy)
Aug 30, 2023 Buy 98 000 Choong Ingrid Stock Option (Right to Buy)
Jul 03, 2023 Buy 750 000 Apelian David Stock Option (Right to Buy)
Apr 30, 2023 Buy 120 000 Vollins James Stock Option (Right to Buy)
Apr 12, 2023 Buy 0 Vollins James
Apr 12, 2023 Buy 0 Kachioff William G
Mar 17, 2023 Sell 2 520 Mayer Eldon C. Iii Common Stock
Mar 17, 2023 Sell 1 875 Mayer Eldon C. Iii Common Stock
Mar 01, 2023 Buy 28 000 Sachdev Amit Stock Option (Right to Buy)
Mar 01, 2023 Buy 28 000 Loh Evan Stock Option (Right to Buy)
Mar 01, 2023 Buy 28 000 Murray Christine Stock Option (Right to Buy)
Mar 01, 2023 Buy 28 000 Glenn Jeffrey S Stock Option (Right to Buy)
Mar 01, 2023 Buy 28 000 Sablich Kim Stock Option (Right to Buy)
Mar 01, 2023 Buy 28 000 Kelly-croswell Lisa Stock Option (Right to Buy)
Mar 01, 2023 Buy 98 000 Mayer Eldon C. Iii Stock Option (Right to Buy)
Mar 01, 2023 Buy 40 000 Dietz Thomas John Stock Option (Right to Buy)
Jan 31, 2023 Buy 170 000 Apelian David Stock Option (Right to Buy)
Jan 26, 2023 Buy 31 500 Mayer Eldon C. Iii Stock Option (Right to Buy)
Jan 26, 2023 Buy 26 750 Atkisson Erik Stock Option (Right to Buy)
Jan 23, 2023 Buy 50 000 Dietz Thomas John Common Stock
Dec 29, 2022 Sell 5 000 Murray Christine Common Stock
Dec 22, 2022 Sell 22 500 Dietz Thomas John Common Stock
Dec 22, 2022 Buy 100 000 Glenn Jeffrey S Common Stock
Aug 16, 2022 Sell 5 000 Apelian David Common Stock
Jul 18, 2022 Buy 30 000 Kelly-croswell Lisa Stock Option (Right to Buy)
Jul 18, 2022 Buy 0 Kelly-croswell Lisa
Mar 14, 2022 Sell 2 266 Ryali Sriram Common Stock
Mar 14, 2022 Sell 1 657 Mayer Eldon C. Iii Common Stock
Mar 11, 2022 Buy 6 000 Sachdev Amit Common Stock
Mar 11, 2022 Buy 12 000 Sachdev Amit Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Sachdev Amit Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Sablich Kim Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Sablich Kim Stock Option (Right to Buy)
Mar 11, 2022 Buy 6 000 Sablich Kim Common Stock
Mar 11, 2022 Buy 143 000 Ryali Sriram Stock Option (Right to Buy)
Mar 11, 2022 Buy 143 000 Ryali Sriram Stock Option (Right to Buy)
Mar 11, 2022 Buy 24 000 Ryali Sriram Common Stock
Mar 11, 2022 Buy 12 000 Murray Christine Stock Option (Right to Buy)
Mar 11, 2022 Buy 98 000 Mayer Eldon C. Iii Stock Option (Right to Buy)
Mar 11, 2022 Buy 6 000 Glenn Jeffrey S Common Stock
Mar 11, 2022 Buy 12 000 Glenn Jeffrey S Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Glenn Jeffrey S Stock Option (Right to Buy)
Mar 11, 2022 Buy 6 000 Loh Evan Common Stock
Mar 11, 2022 Buy 12 000 Loh Evan Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Loh Evan Stock Option (Right to Buy)
Mar 11, 2022 Buy 6 000 Dietz Thomas John Common Stock
Mar 11, 2022 Buy 24 000 Dietz Thomas John Stock Option (Right to Buy)
Mar 11, 2022 Buy 47 000 Cory David A Common Stock
Mar 11, 2022 Buy 38 000 Atkisson Erik Stock Option (Right to Buy)
Mar 11, 2022 Buy 6 000 Apelian David Common Stock
Mar 11, 2022 Buy 12 000 Apelian David Stock Option (Right to Buy)
Mar 11, 2022 Buy 12 000 Apelian David Stock Option (Right to Buy)
Jan 07, 2022 Sell 1 560 Mayer Eldon C. Iii Common Stock
Sep 30, 2021 Buy 180 000 Atkisson Erik Stock Option (Right to Buy)
Sep 22, 2021 Buy 0 Atkisson Erik
Jul 29, 2021 Buy 17 500 Mayer Eldon C. Iii Stock Option (Right to Buy)
Jul 29, 2021 Buy 48 750 Cory David A Stock Option (Right to Buy)
Jul 29, 2021 Buy 30 000 Ryali Sriram Stock Option (Right to Buy)
May 10, 2021 Buy 87 000 Ryali Sriram Stock Option (Right to Buy)
Apr 23, 2021 Buy 25 000 Sablich Kim Stock Option (right to buy)
Apr 23, 2021 Buy 0 Sablich Kim
Apr 09, 2021 Buy 1 000 Dietz Thomas John Common Stock
Apr 09, 2021 Buy 1 500 Dietz Thomas John Common Stock
Mar 12, 2021 Buy 71 250 Shaffer James P Stock Option (Right to Buy)
Mar 12, 2021 Buy 11 875 Shaffer James P Common Stock
Mar 12, 2021 Buy 5 000 Sachdev Amit Common Stock
Mar 12, 2021 Buy 10 000 Sachdev Amit Stock Option (Right to Buy)
Mar 12, 2021 Buy 97 500 Ryali Sriram Stock Option (Right to Buy)
Mar 12, 2021 Buy 16 250 Ryali Sriram Common Stock
Mar 12, 2021 Buy 71 250 Patton Stephana Eilene Stock Option (Right to Buy)
Mar 12, 2021 Buy 11 875 Patton Stephana Eilene Common Stock
Mar 12, 2021 Buy 5 000 Murray Christine Common Stock
Mar 12, 2021 Buy 10 000 Murray Christine Stock Option (Right to Buy)
Mar 12, 2021 Buy 71 250 Mayer Eldon C. Iii Stock Option (Right to Buy)
Mar 12, 2021 Buy 11 875 Mayer Eldon C. Iii Common Stock
Mar 12, 2021 Buy 5 000 Loh Evan Common Stock
INSIDER POWER
75.143
Last 100 transactions
Buy: 3 822 136 | Sell: 42 378 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 75.143.

In total, the insiders bought 3 822 136 and sold 42 378 EIGR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals. Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe... EIGR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT